Amber Specialty Pharmacy Selected to Dispense P...
Amber Specialty Pharmacy Selected to Dispense Adbry™ (tralokinumab-ldrm) for the Treatment of Moderate to Severe Atopic Dermatitis
- March 25, 2022
- Amber Specialty Pharmacy
- Inflammatory, Press Releases
OMAHA, Neb. (Mar. 25, 2022) – Amber Specialty Pharmacy announces that they have begun dispensing Adbry™ (tralokinumab-ldrm), an anti-IL 13 monoclonal antibody approved by the United States Food and Drug Administration for the treatment of adults with moderate to severe atopic dermatitis. Adbry™ is marketed by LEO Pharma Inc., the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology. LEO Pharma Inc.’s offices are located in Madison, New Jersey.
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by dry skin, intense itching and recurrent relapsing eczematous lesions with a heterogeneous clinical presentation. AD lesions are characterized by erythema (skin turning red or purple depending on normal skin color), induration (hardening)/papulation (formulation of papules), lichenification, oozing/crusting. AD affects up to 10% of adults worldwide.
Amber Specialty Pharmacy’s high touch, whole-health service model will support affected patients and dermatology offices throughout the country.
“Uncontrolled Atopic Dermatitis causes pain and even embarrassment and can make day-to-day tasks feel overwhelming. We understand how important it is to make sure patients living with AD have the medicine and support they need to manage their condition,” said Casey Decker, president of Amber Specialty Pharmacy. “We are proud that LEO Pharma recognizes our passion and ability to deliver meaningful results to our patients.”
For more information about Amber Specialty Pharmacy services, call (888) 370-1724.
About Amber Specialty Pharmacy Amber Specialty Pharmacy, a Hy-Vee, Inc. subsidiary, is a pioneer and leader in the specialty pharmacy industry with more than 23 years of experience providing specialized care for persons with chronic, complex medical conditions. Amber Specialty Pharmacy has built an exceptional reputation by providing personalized support and quality clinical care to patients and families. This comprehensive care approach supports the medical, emotional, financial and administrative needs of patients throughout the United States. Amber Specialty Pharmacy is accredited by the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy headquarters are located in Omaha, Nebraska, with an additional 20 locations throughout the United States and Puerto Rico. Amber Specialty Pharmacy was named the 2020 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy.